Edinburgh Molecular Imaging Ltd:企業の製品パイプライン分析2018

【英語タイトル】Edinburgh Molecular Imaging Ltd - Product Pipeline Analysis, 2018 Update

GlobalDataが出版した調査資料(DATA904C0461)・商品コード:DATA904C0461
・発行会社(調査会社):GlobalData
・発行日:2018年7月
・ページ数:27
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD1,500 ⇒換算¥222,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥333,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Edinburgh Molecular Imaging Ltd (EM Imaging) is a biotechnology company that develops optical molecular imaging technology. The company offers discovery and development of small molecules and peptides. It designs agents to improve the diagnosis and treatment of cancer and lung diseases. EM Imaging’s agents include EMI-137 for CRC Lesion, EMI-200 for inflammation, EMI-300 and 350 for lung infection, EMI-400 for lung fibrosis, EMI-500 for breast cancer, and EMI-600 for single pulmonary nodules. The company develops optical imaging platform which shows the increased fluorescent signal from the optical agents on target engagement in a diseased patient. EM Imaging is headquartered in Edinburgh, the UK.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Edinburgh Molecular Imaging Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Edinburgh Molecular Imaging Ltd Company Overview 4
Edinburgh Molecular Imaging Ltd Company Snapshot 4
Edinburgh Molecular Imaging Ltd Pipeline Products and Ongoing Clinical Trials Overview 4
Edinburgh Molecular Imaging Ltd – Pipeline Analysis Overview 7
Edinburgh Molecular Imaging Ltd – Key Facts 7
Edinburgh Molecular Imaging Ltd – Major Products and Services 8
Edinburgh Molecular Imaging Ltd Pipeline Products by Development Stage 9
Edinburgh Molecular Imaging Ltd Ongoing Clinical Trials by Trial Status 11
Edinburgh Molecular Imaging Ltd Pipeline Products Overview 12
EMI-137 12
EMI-137 Product Overview 12
EMI-137 Clinical Trial 13
EMI-200 14
EMI-200 Product Overview 14
EMI-300/350 15
EMI-300/350 Product Overview 15
EMI-400 16
EMI-400 Product Overview 16
EMI-500 17
EMI-500 Product Overview 17
EMI-600 18
EMI-600 Product Overview 18
Edinburgh Molecular Imaging Ltd – Key Competitors 19
Edinburgh Molecular Imaging Ltd – Key Employees 20
Edinburgh Molecular Imaging Ltd – Locations And Subsidiaries 21
Head Office 21
Recent Developments 22
Edinburgh Molecular Imaging Ltd, Recent Developments 22
Sep 20, 2017: Edinburgh Molecular Imaging Commences Phase II European Cancer Trial 22
Mar 09, 2016: Edinburgh Molecular Imaging Awarded Innovate UK Grant To Qualify The Role Of EMI-137 In Colorectal Cancer Lesion Detection 22
Appendix 24
Methodology 24
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Edinburgh Molecular Imaging Ltd Pipeline Products and Ongoing Clinical Trials Overview 4
Edinburgh Molecular Imaging Ltd Pipeline Products by Equipment Type 5
Edinburgh Molecular Imaging Ltd Pipeline Products by Indication 6
Edinburgh Molecular Imaging Ltd Ongoing Clinical Trials by Trial Status 6
Edinburgh Molecular Imaging Ltd, Key Facts 7
Edinburgh Molecular Imaging Ltd, Major Products and Services 8
Edinburgh Molecular Imaging Ltd Number of Pipeline Products by Development Stage 9
Edinburgh Molecular Imaging Ltd Pipeline Products Summary by Development Stage 10
Edinburgh Molecular Imaging Ltd Ongoing Clinical Trials by Trial Status 11
Edinburgh Molecular Imaging Ltd Ongoing Clinical Trials Summary 11
EMI-137 - Product Status 12
EMI-137 - Product Description 12
EMI-137 - A Phase IIb, Open Label Study for the Detection of Dysplastic Colorectal Polyps during Colonoscopy after EMI-137 Injection in Patients with High Risk of Colorectal Cancer 13
EMI-200 - Product Status 14
EMI-200 - Product Description 14
EMI-300/350 - Product Status 15
EMI-300/350 - Product Description 15
EMI-400 - Product Status 16
EMI-400 - Product Description 16
EMI-500 - Product Status 17
EMI-500 - Product Description 17
EMI-600 - Product Status 18
EMI-600 - Product Description 18
Edinburgh Molecular Imaging Ltd, Key Employees 20
Glossary 26

List of Figures
Edinburgh Molecular Imaging Ltd Pipeline Products by Equipment Type 5
Edinburgh Molecular Imaging Ltd Pipeline Products by Development Stage 9
Edinburgh Molecular Imaging Ltd Ongoing Clinical Trials by Trial Status 11

★調査レポート[Edinburgh Molecular Imaging Ltd:企業の製品パイプライン分析2018] (コード:DATA904C0461)販売に関する免責事項を必ずご確認ください。
★調査レポート[Edinburgh Molecular Imaging Ltd:企業の製品パイプライン分析2018]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆